System-level immune monitoring reveals new pathophysiological features in hepatitis-associated aplastic anemia

Blood Adv. 2023 Aug 8;7(15):4039-4045. doi: 10.1182/bloodadvances.2022008224.

Cecile Braudeau^{1

2}, Laurence Delbos², Marie-Laure Couec³, Gwenvael Danic², Justine Chevreuil¹, Camille Lecuroux^{1

2}, Audrey Grain³, Marion Eveillard⁴, Fanny Rialland³, Flore Sicre de Fontbrune⁵, Gaelle Beriou², Nicolas Degauque², David Michonneau^{5

6}, Regis Josien^{1

2}, Régis Peffault de Latour^{5

6

7}, Caroline Thomas³, Jerome C Martin^{1

2}

¹ Laboratoire d'Immunologie, CHU Nantes, Centre d'Immunomonitorage Nantes Atlantique, Nantes Université, Nantes, France.
² CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Institut de transplantation urologie-néphrologie, Nantes Université, Nantes, France.
³ CHU Nantes, Service d'Oncologie-Hématologie et Immunologie Pédiatrique, Nantes Université, Nantes, France.
⁴ Laboratoire d'Hematologie, CHU Nantes, Nantes Université, Nantes, France.
⁵ Hematology Transplantation, Saint-Louis Hospital, Paris, France.
⁶ Université Paris Cité, INSERM U976, Paris, France.
⁷ Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint-Louis Hospital, Paris, France.

No abstract available

MeSH terms